Friday 26 July 2019

Ovarian cancer drug olaparib 'can delay disease in newly diagnosed'

Ovarian cancer drug olaparib 'can delay disease in newly diagnosed' A drug for advanced ovarian cancer has been approved for use in newly diagnosed patients in England, after a trial showed it could delay progression of the disease for three years.

Up to 600 women with a hereditary type of the disease could benefit each year. BBC News

See also:

No comments:

Post a Comment